5min chapter

The Deep End by ODF cover image

Raising $175M to Translate Nature Into Medicine with Viswa Colluru

The Deep End by ODF

CHAPTER

The Risk Averse Biotechnology Industry

The efficient market hypothesis goes something like, hey, every good idea there is that is obvious has been tried. And or if there's untapped value in the market, an efficient market will recognize it and equilibrate supply and demand. In a biotech bear market, people are less likely to bet on potential than they are on realized value. The one advantage we tend to have in biotech is that there's very low commercial or market risk.

00:00

Get the Snipd
podcast app

Unlock the knowledge in podcasts with the podcast player of the future.
App store bannerPlay store banner

AI-powered
podcast player

Listen to all your favourite podcasts with AI-powered features

Discover
highlights

Listen to the best highlights from the podcasts you love and dive into the full episode

Save any
moment

Hear something you like? Tap your headphones to save it with AI-generated key takeaways

Share
& Export

Send highlights to Twitter, WhatsApp or export them to Notion, Readwise & more

AI-powered
podcast player

Listen to all your favourite podcasts with AI-powered features

Discover
highlights

Listen to the best highlights from the podcasts you love and dive into the full episode